Ri Cui

Wenzhou Medical University

H指数:37

被引数:4,194

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination of B-AP15 and HSP90 inhibitor tanespimycin induces ROS-mediated cytotoxicity in human lung cancer cells

B-AP15与HSP90抑制剂tanespimycin的组合可诱导人肺癌细胞的ROS介导的细胞毒性

BMC Pharmacology and Toxicology

IF0

2025-10-300

OAAI

The glutamyl-prolyl-tRNA synthetase 1 inhibitor halofuginone exerts synergistic antitumor effects with bortezomib in colon cancer cells

Halofuginone，一种谷氨酰-脯氨酰-tRNA合成酶1抑制剂，在结肠癌细胞中与硼替佐米表现出协同抗肿瘤效应。

Toxicology and Applied Pharmacology

IF3.4

2025-10-230

PRE

Usenamine A, an RGS2 inhibitor, exerts anti-NSCLC activity and enhances cytotoxicity of gemcitabine by inducing ER stress and Notch1-mediated autophagy

Usenamine A，一种RGS2抑制剂，通过诱导ER应激和Notch1介导的细胞自噬，发挥抗NSCLC活性并增强吉西他滨的细胞毒性。

Bioorganic Chemistry

IF4.7

2025-09-170

PRE

Panobinostat potentiates adagrasib-induced cell death by triggering autophagy in human non-small cell lung cancer

帕比司他通过诱导自噬增强阿达格拉西布诱导的人非小细胞肺癌细胞死亡

Cell Death Discovery

IF7

2025-08-010

HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway (vol 15,603,2024)

HOXB8通过激活STAT3通路介导结直肠癌细胞对西妥昔单抗的抵抗（卷15，603，2024）

DISCOVER ONCOLOGY

IF2.9

2025-01-300

Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-05-013

OAAI

Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways

NEOPLASIA

IF7.7

2024-05-017

OAAI

Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells

CELL DEATH DISCOVERY

IF7

2023-10-135

OAAI

Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2023-10-018

PRE

Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells

NEOPLASIA

IF7.7

2023-05-016

OAAI

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways

PHYTOMEDICINE

IF8.3

2022-04-0114

PRE

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-257

OAAI

Dissecting miRNA signature in colorectal cancer progression and metastasis

CANCER LETTERS

IF10.1

2021-03-0167

PREAI

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors

THERANOSTICS

IF13.3

2021-01-0116

OAAI

miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling

CELL DEATH & DISEASE

IF9.6

2020-09-2230

OAAI

Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells

ONCOGENE

IF7.3

2020-04-0229

PREAI

miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer

TSPAN12和GATA6 miR-196b-5p-mediated下调促进非小细胞肺癌进展

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2020-02-10128

OAAI

Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer

姜黄素衍生物WZ35通过ros-yap-jnk信号通路抑制乳腺癌肿瘤细胞生长

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2019-11-0896

OAAI

Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway

MOLECULAR CARCINOGENESIS

IF3.2

2019-05-089

PREAI

Ri Cui

个人简介

教育背景

工作经历

荣誉奖项

研究方向